Research Group Cancer Research

 1
 

 

The team of Florian Grebien aims to contribute to a better understanding of the molecular mechanisms of leukemia development through the development and use of novel tools for functional evaluation of oncogenic aberrations. Our research is focused on Acute Myeloid Leukemia (AML), a cancer 2 of white blood cells that is characterized by the rapid growth of abnormal myeloid cells 3. The accumulation of aberrantly proliferating myeloid progenitor cells interferes with the production of normal blood cells 4, leading to bone marrow failure.

 

 

The concept of personalized treatment in modern medicine will require an improved molecular understanding of the pathological processes underlying neoplastic initiation and progression. Recent large-scale sequencing studies have revealed a high number of novel genetic lesions that may contribute to tumorigenesis. Thorough experimental validation of these newly identified mutations using standard methodologies, however, cannot keep up with the pace of continuously accelerating data generation. Therefore, the current challenge in modern biology is to adapt and develop novel tools for functional characterization of disease processes.

 

In a project funded by the European Research Council (ERC), we are employing novel cellular expression systems of AML oncoproteins in combination with cutting-edge proteomic-, genomic- and transcriptomic approaches in a robust experimental pipeline that enables the rapid characterization of effects of AML oncoprotein expression in a multilayered, global fashion. This is complemented by genome-scale functional studies to detect specific molecular vulnerabilities that are dependent on the oncogenic mutation of interest. Newly identified molecular mechanisms of mutated alleles are validated using primary patient-derived leukemic cells and translational mouse models of leukemia.

 

 

Head of Research Group Cancer Research

Florian Grebien

Univ.-Prof. Dr.rer.nat. Florian Grebien
T +43 1 25077-4200
E-Mail to Florian Grebien
to vCard  5

 

Staff Research Group Cancer Research

 

 

Jessica Ebner BSc.

 

E-Mail to Jessica Ebner

 
Elizabeth Claire Heyes

Elizabeth Claire Heyes MSc.
T +43 1 25077-4202
E-Mail to Elizabeth Claire Heyes
to vCard  6

 
 
Fabio Liberante

Fabio Liberante PhD.
T +43 1 25077-4207
E-Mail to Fabio Liberante
to vCard  8

 
Gabriele Manhart

Dipl.-Ing. Gabriele Manhart
T +43 1 25077-4202
E-Mail to Gabriele Manhart
to vCard  9

 
Torben Redmer

Dr.rer.nat. Torben Redmer
T +43 1 25077-4213
E-Mail to Torben Redmer
to vCard  10

 
Luisa Schmidt

Mag.rer.nat. Luisa Schmidt
T +43 1 25077-4202
E-Mail to Luisa Schmidt
to vCard  11

 
Johannes Schmöllerl

Johannes Schmöllerl MSc. BSc.
T +43 1 25077-4202
E-Mail to Johannes Schmöllerl
to vCard  12

 
Stefan Terlecki-Zaniewicz

Stefan Terlecki-Zaniewicz MSc.
T +43 1 25077-4202
E-Mail to Stefan Terlecki-Zaniewicz
to vCard  13

 
Selina Tröster

MRes Selina Tröster
T +43 1 25077-4202
E-Mail to Selina Tröster
to vCard  14

  

Administration

Manuela Thullner

Monday to Friday

8.00 - 15.30

e-mail to Manuela Thullner

T +43 1 250 77 - 4201

 


 

Contact

Institute for Medical Biochemistry
1210 Vienna, Veterinärplatz 1

(Building HA)

T +43 1 25077-4201
F +43 1 25077-4290
E-Mail to Institute for Medical Biochemistry

Arrival to the University of Veterinary Medicine 15